Email Alert | RSS    帮助

中国防痨杂志 ›› 2009, Vol. 31 ›› Issue (4): 192-194.

• 论著 • 上一篇    下一篇

血行播散性肺结核362例临床分析

周文琳;田荆芳   

  1. 辽宁省鞍山市千山医院 鞍山 114001
  • 出版日期:2009-04-10 发布日期:2011-11-03

Clinical analysis on 362 hematogenous disseminated pulmonary tuberculosis

Zhou Wenlin, Tian Jingfang   

  1. Anshan Qianshan Hospital, Anshan 114001, China
  • Online:2009-04-10 Published:2011-11-03

摘要: 目的分析血行播散性肺结核临床特点。方法回顾分析鞍山市千山医院1998—2007年住院患者362例血行播散性肺结核患者临床特点、治疗、预后等。结果以青壮年为多,占62.0%,老年患者有上升趋势,占21.0%。临床症状发热占86.1%,呼吸道症状以咳嗽、乏力、气促、盗汗、胸痛等症状居多,伴有结脑者有头痛、恶心、呕吐等。临床确诊时间:30d以内占50.3%,少数病人至4个月以上确诊。痰菌阳性率37.8%。PPD试验阳性反应58.6%,血清抗结核抗体阳性44.8%。急性血行播散性肺结核68.5%,亚急性和慢性血行播散性肺结核31.5%。胸部X线典型粟粒性肺结核阴影占68.5%,并发肺外结核占40.0%。非结核并发症占68.2%。经联合抗结核治疗同时治疗并发症。除结脑脑疝死亡2例外,余者均好转。结论血行播散性肺结核症状严重,常合并其他脏器结核病,必须给予高效、敏感抗结核药治疗,并对肺外结核病、并发症亦予以积极治疗,并辅以营养与支持疗法,能获得满意疗效。

关键词: 关键词:结核, 肺/诊断, 结核, 肺/药物疗法

Abstract: ObjectiveTo analyse clinical characteristics of hematogenous disseminated pulmonary tuberculosis. MethodsWe analyzed retrospectively the data of clinical features, treatment and prognosis of 362 patients with hematogenous disseminated pulmonary tuberculosis who hospitalized in our hospital from 1998 to 2007. ResultsMost patients with hematogenous disseminated pulmonary tuberculosis were young and they accounted for 62.0%. The elderly patients showed an upward tendency and they accounted for 21.0%. The fever accounted for 86.1% in clinical symptom. The respiratory symptom mainly included cough, fatigue, tachypnea, night sweat and chest pain. The symptoms of headache, nausea and vomiting would be seen patients complicated with tubercular meningitis. The time of clinical confirmed diagnosis: patients confirmed diagnosis within 30 days accounted for 50.3%, a few patients were diagnosed over four months. The rate of sputum bacilli positive was 37.8%,the positive reaction of PPD test 58.6%, the positive rate of serum antitubercular antibody 44.8%. The patients with acute hematogenous disseminated pulmonary tuberculosis accounted for 68.5%, the patients with subacute and chronic hematogenous disseminated pulmonary tuberculosis 31.5%. Those patients with typical military nodes in X-ray accounted for 68.5%, the patients complicated with extrapulmonary tuberculosis 40.0%. The non-tuberculosis complication accounted for 68.2%. Antituberculosis treatment with 4 or 5 drugs and the treatment for non-tuberculosis complication were given at the same time.Except two deaths due to cerebral hernia, most patients were improved. ConclusionsHematogenous disseminated pulmonary tuberculosis is a kind of critical pulmonary tuberculosis with serious symptom, especially when complicated with tuberculosis in other viscera. The effective antituberculosis treatment should be given in time for those patients with hematogenous disseminated pulmonary tuberculosis and extraplumoary tuberculosis. Treatment for non-tuberculosis complication is also performed properly. Adjuvant and supportive care including immunopotentiators maybe improve symptoms for these patients.

Key words: tuberculosis,pulmonary/diagnosis, tuberculosis,pulmonary/drug therapy